As Executive Director of UT System Office of Technology Commercialization and the UT Horizon Fund, Mr. Allinson serves as the technology commercialization principal under Patricia Hurn, Vice Chancellor for Research and Innovation. He directs access to resources and shared services necessary for commercialization of technology.
A key role for Mr. Allinson is to lead due diligence review and requirements for investment into UT startup companies. Capitalized in 2011 with a $10 million investment and recapitalized in 2013 with an additional $12.5 million, the UT Horizon Fund serves as the strategic venture fund to act as catalyst for commercialization. Focus is placed on investments that serve UT System’s dual mission: strategic mission to commercialize technology and financial mission to provide a return on investment to UT System institutions. Since starting the UT Horizon Fund in 2012, the UT Horizon Fund makes investments ranging from seed investments to late stage, from a broad class of industry sectors including pharmaceutical, medical device, nanotechnology, communications and web media.
Prior to his position at UT System, he served as Director of Technology Transfer at Ohio University, helping to monetize royalty revenue of SOMAVERT®, pharmaceutical product marketed by Pfizer, a deal valued at $52 million. Mr. Allinson served as the liaison to the Technology Commercialization Committee of the Ohio University Foundation Board and Co-Chair of University Business Development Committee. He previously served as Director of Geisinger Ventures, a corporate healthcare institutional venture firm for one of the largest physician clinics in the world and a leader in electronic medical records innovation. At Geisinger, he founded the technology commercialization office and led deals in biopharmaceutical, medical device, laboratory medicine, information technology and healthcare service areas. He previously served as a H. J. Heinz Technology Commercialization Fellow at Carnegie Mellon University and was part of the critical growth of several startup companies.
He currently serves as a member of the licensing committee of the national Association for University Technology Managers, and is an organizer for a trade group on best practices for university venture funds. Bryan received an MBA from Carnegie Mellon University, and a dual bachelors degree in chemical engineering and chemistry from the University of Pittsburgh.
One of Mr. Allinson’s patents is actively being used by the United States military in a class of products against chemical and biological warfare attacks.
The University of Texas System
702 Colorado Street
Colorado Bldg, Suite 6.620
Austin, TX 78701
Phone: (512) 499-4397
Fax: (512) 499-4523